Natural history of Charcot–Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life
- 17 December 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 31 (2), 175-178
- https://doi.org/10.1007/s10072-009-0202-z
Abstract
Charcot–Marie-Tooth (CMT) disease is the most frequent inherited neuropathy, no therapies are available at the moment but clinical trials are ongoing. For that reason it is very important to know the natural history of the disease. We report the results of the natural history of clinical features and quality of life (QoL) in patients with CMT2. Twenty patients were enrolled. At recruitment and at follow-up (2 years), all patients underwent neurological evaluation, QoL and disability assessments. The study-end evaluation took place 20–28 months after the baseline evaluation. During the 2-year follow-up period, CMT2 patients showed a mild reduction of strength of distal muscles of upper limbs and proximal muscles of lower limbs, a worsening sensory function and a mild increase in walking disability. However, there was no relevant worsening of QoL, except for a mild deterioration of one mental health domain.This publication has 19 references indexed in Scilit:
- Experimental Therapeutics in Hereditary Neuropathies: The Past, the Present, and the FutureNeurotherapeutics, 2008
- Natural history of CMT1A including QoL: A 2-year prospective studyNeuromuscular Disorders, 2008
- A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]Pharmacological Research, 2006
- 136th ENMC International Workshop: Charcot–Marie–Tooth Disease Type 1A (CMT1A)8–10 April 2005, Naarden, The NetherlandsNeuromuscular Disorders, 2006
- 131st ENMC International workshop: Selection of Outcome Measures for Peripheral Neuropathy Clinical Trials: 10–12 December 2004, Naarden, The NetherlandsNeuromuscular Disorders, 2006
- Charcot–Marie–Tooth disease impairs quality of lifeNeurology, 2005
- Reliability and validity of the CMT neuropathy score as a measure of disabilityNeurology, 2005
- Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth diseaseNature Medicine, 2004
- The Italian SF-36 Health Survey: Translation, Validation and NormingJournal of Clinical Epidemiology, 1998
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992